Briefing From The Editor -- IBM Stock

International Business Machines logged a -0.4% change during today's afternoon session, and is now trading at a price of $133.54 per share. The S&P 500 index moved 1.0%. IBM's trading volume is 1,319,900 compared to the stock's average volume of 4,530,409.

International Business Machines trades -5.15% away from its average analyst target price of $140.79 per share. The 15 analysts following the stock have set target prices ranging from $110.0 to $162.0, and on average have given International Business Machines a rating of hold.

If you are considering an investment in IBM, you'll want to know the following:

  • International Business Machines's current price is 129.0% above its Graham number of $58.3, which implies that at its current valuation it does not offer a margin of safety

  • International Business Machines has moved -500.3% over the last year, and the S&P 500 logged a change of 1493.0%

  • Based on its trailing earnings per share of 2.25, International Business Machines has a trailing 12 month Price to Earnings (P/E) ratio of 59.4 while the S&P 500 average is 15.97

  • IBM has a forward P/E ratio of 13.4 based on its forward 12 month price to earnings (EPS) of $9.98 per share

  • The company has a price to earnings growth (PEG) ratio of 4.61 — a number near or below 1 signifying that International Business Machines is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 5.61 compared to its sector average of 6.23

  • International Business Machines Corporation, together with its subsidiaries, provides integrated solutions and services worldwide.

  • Based in Armonk, the company has 288,300 full time employees and a market cap of $121.26 Billion. International Business Machines currently returns an annual dividend yield of 4.9%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.